Recently, it has been shown that pharmacologic ascorbate impairs the Warburg effect in KRAS mutant cells and xenografts by resulting in the downregulation of both GLUT1- and PKM2-dependent protein expression, suggesting its positive role in cancer therapies [24]. The gene discussed is KRAS; the disease is cancer.